Queensway Glue is a modern hybrid cannabis strain derived from the genetics of Swansea Berry. This strain represents a cyclical lineage, as it is both a descendant of and the parent to the Swansea Berry variety. Cultivation of Queensway Glue is characterized by a moderate difficulty level, making it suitable for both indoor and outdoor environments. Growers can expect a high yield from this plant, which reaches maturity after a 56-day flowering period.

The chemical profile of Queensway Glue is defined by a complex arrangement of terpenes, led by dominant myrcene, followed by caryophyllene, terpinolene, and limonene. The secondary and tertiary compounds—comprising pinene, humulene, ocimene, beta-pinene, linalool, nerolidol, guaiol, p-cymene, and bisabolol—contribute to an intricate sensory experience. This specific balance of aromatic hydrocarbons creates a distinct terpene signature that defines the strain's olfactory and gustatory profile.

As a THC-dominant hybrid, Queensway Glue is primarily utilized for its ability to induce effects of relaxation, happiness, and an uplifted mood. These therapeutic properties make the strain a common choice for patients seeking support with stress management, pain relief, and sleep aid. Its genetic influence is underscored by its notable role as an ancestor within its own lineage, cementing its place in the development cycle of Swansea Berry.